Dr. Reddy’s Laboratories Ltd. has secured USFDA review for its proposed interchangeable abatacept biosimilar, DRL_AB, positioning itself as the first to file a BLA in this segment and strengthening its biologics footprint in the US market.
GSK has secured European Commission approval for Exdensur (depemokimab), a twice-yearly treatment for severe asthma and chronic rhinosinusitis with nasal polyps, offering sustained control for patients with uncontrolled type 2 inflammation.
Dr Reddy’s Laboratories has acquired the India trademarks of two hormone replacement therapy drugs from Mercury Pharma for $32.15 million, strengthening its women’s health portfolio and marking its entry into the growing HRT segment.
Eli Lilly is establishing India as a strategic center point in its global supply chain, with the assistance of the robust contract manufacturing ecosystem
Pharma companies delivered mixed Q3 FY26 numbers as earnings hit markets. Some firms posted strong revenue and profit growth while others faced margin pressure. Investors reacted fast, with stocks rising or dipping based on results and outlooks.
.png)
Zydus Lifesciences has received USFDA approval for Ammonium Lactate Cream, 12%, a treatment for dry skin and ichthyosis vulgaris.
Biological E Limited has received Phase II prequalification from the World Health Organization for its Novel Oral Polio Vaccine type 2, strengthening global supply and boosting efforts to control vaccine-derived polio outbreaks worldwide.
Sanofi has finalized its acquisition of Dynavax, adding hepatitis B vaccine HEPLISAV-B and a shingles vaccine candidate to its portfolio. The $15.50 per share deal strengthens Sanofi’s position in adult immunization.
The merger of Auro Vaccines and Curateq Biologics, a part of Aurobindo Pharma, was approved today during a board meeting of the company held.
.png)
Eli Lilly has agreed to acquire Orna Therapeutics in a deal valued at up to $2.4 billion, strengthening its position in in vivo CAR-T therapies and expanding options for patients with B cell-driven autoimmune diseases.
, CDSCO.jpg)